Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIIA pseudogene 1 (GTF3AP1) is a non-protein-coding genomic sequence that shares high similarity with the protein-coding GTF3A gene. Like other pseudogenes, it is presumed to have lost the capacity to encode a functional protein due to sequence alterations, and there is no evidence it has a direct biological function or role as a therapeutic target. The related functional gene (GTF3A) encodes a zinc finger transcription factor essential for the transcription of 5S ribosomal RNA, but GTF3AP1 itself is considered genomically inert[5][1].\n\nKey clarification:\n- If you are seeking information relevant to disease biology, drug interactions, or molecular function, you should refer to the functional gene "General transcription factor IIIA" (GTF3A), not this pseudogene.\n- **GTF3AP1** is unlikely to be found in drug or biomarker databases as a valid therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIIA pseudogene 1 (GTF3AP1).